Frequency Therapeutics, Inc. Securities Litigation

Filing Deadline: August 02, 2021

If you purchased a significant amount of shares of Frequency Therapeutics Inc. Common Stock (NASDAQ: FREQ), you have certain options. Investors should contact us before August 02, 2021.


Lawsuit Overview

Defendant:Frequency Therapeutics Inc. Common Stock
Date Filed:June 3rd, 2021
Sector:Health Care
Industry:Major Pharmaceuticals
Class Start Date:November 16th, 2020
Class End Date:March 22nd, 2021

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business prospects. Specifically, the Complaint alleges that during the Class Period, Defendants misled investors about the Phase 2a study of FX-322.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Frequency Therapeutics Inc. Common Stock

First Identified Complaint

Paul Evans, et al. v. Frequency Therapeutics, Inc., et al.

Date Filed:June 3rd, 2021
Class Period Start:November 16th, 2020
Class Period End:March 22nd, 2021
First Identified Complaint Filings
#Document TitleFiling Date